Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade

Cancer patients with low or absent pre-existing anti-tumour immunity (“cold” tumours) respond poorly to treatment with immune checkpoint inhibitors (ICPI). In order to render these patients susceptible to ICPI, initiation of de novo tumour-targeted immune responses is required. This involves trigger...

Descripción completa

Detalles Bibliográficos
Autores principales: Appleton, Elizabeth, Hassan, Jehanne, Chan Wah Hak, Charleen, Sivamanoharan, Nanna, Wilkins, Anna, Samson, Adel, Ono, Masahiro, Harrington, Kevin J., Melcher, Alan, Wennerberg, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558396/
https://www.ncbi.nlm.nih.gov/pubmed/34733287
http://dx.doi.org/10.3389/fimmu.2021.754436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558396/
https://www.ncbi.nlm.nih.gov/pubmed/34733287
http://dx.doi.org/10.3389/fimmu.2021.754436

Ejemplares similares